The biweekly dactinomycin regimen has a higher CR rate than the weekly IM methotrexate regimen in low-risk GTN, a generally curable disease.
No takes yet. Share an insight, caveat, or question.
Osborne et al. (2011) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: